Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria - experiences from the Danish Cystic Fibrosis cohort study

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Qvist, Tavs ^a   Johansen, Isik S ^b   Pressler, Tania ^a   Høiby, Niels ^a   Andersen, Aase B ^a   Katzenstein, Terese L ^a   Bjerrum, Stephanie ^b  

^a University of Copenhagen   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Abscessus; Avium; CF; LAM; Lipoarabinomannan; Nontuberculous; NTM

Indexed keywords

AMIKACIN; CLARITHROMYCIN; ETHAMBUTOL; LIPOARABINOMANNAN; MACROLIDE; RIFAMPICIN; BACTERIAL ANTIGEN; BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; CYSTIC FIBROSIS; DENMARK; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FEMALE; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; POINT OF CARE TESTING; PREVALENCE; PROSPECTIVE STUDY; PROTEIN ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; URINALYSIS; URINE LEVEL; URINE PARTICLE ANALYZER; YOUNG ADULT; ATYPICAL MYCOBACTERIUM; CLINICAL TRIAL; COMPLICATION; HOSPITAL INFORMATION SYSTEM; IMMUNOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; URINE;

ADULT; ANTIGENS, BACTERIAL; BIOMARKERS; COHORT STUDIES; CROSS REACTIONS; CYSTIC FIBROSIS; DENMARK; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84923930509     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0655-4     Document Type: Article

References (40)

1. Qvist T, Pressler T, Thomsen VO, Skov M, Iversen M, Katzenstein TL: Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish Patient Population. Transplant Proc 2012, 45(1873-2623):342-345.
2. Qvist T, Gilljam M, Jönsson B, Taylor-Robinson D, Jensen-Fangel S, Wang M, Svahn A, Kötz K, Hansson L, Hollsing A, Hansen CR, Finstad PL, Pressler T, Høiby N, Katzenstein TL: Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. J Cyst Fibros 2014. http://dx.doi.org/10.1016/j.jcf.2014.08.002.
3. Esther CR Jr, Esserman DA, Gilligan P, Kerr A, Noone PG, Esther CR: Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 2010, 9:117-123.
4. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Winthrop K, Wallace RJ Jr: An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
5. Sarkar P, Biswas D, Sindhwani G, Rawat J, Kotwal A, Kakati B: Application of lipoarabinomannan antigen in tuberculosis diagnostics: current evidence. Postgrad Med J 2014, 90(1061):155-163.
6. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D: Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J 2011, 38:1398-1405.
7. Lawn SD: Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis 2012, 12:103.
8. Lawn SD, Kerkhoff AD, Vogt M, Wood R: Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012, 12:201-209.
9. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl Smit R, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A: Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 2010, 5:e9848.
10. Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Walensky RP, Freedberg KA, Bassett IV: Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based study. BMC Infect Dis 2014, 14:110.
11. Gounder CR, Kufa T, Wada NI, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant A, Dorman S, Chaisson RE, Churchyard GJ: Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis. J Acquir Immune Defic Syndr 2011, 58:219-223.
12. Nakiyingi L, Moodley VM, Manabe YC, Nicol MP, Holshouser M, Armstrong DT, Zemanay W, Sikhondze W, Mbabazi O, Nonyane BAS, Shah M, Joloba ML, Alland D, Ellner JJ, Dorman SE: Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. J Acquir Immune Defic Syndr 2014, 66(3):270-279.
13. Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A: Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cyst Fibros 2009, 8:135-142.
14. Lawn SD, Dheda K, Kerkhoff AD, Peter JG, Dorman S, Boehme CC, Nicol MP: Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infect Dis 2013, 13:407.
15. Qvist T, Pressler T, Katzenstein TL, Hoiby N: Elevated levels of antibodies against Mycobacterium abscessus in cystic fibrosis patients is associated with active lung disease. PediatrPulmonol 2012, 47(Suppl 3(1099-0496)):335.
16. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K: Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med 2010, 16:262-270.
17. Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, Binder A, Meldau R, Hardy A, Dheda K: Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 2012, 40:1211-1220.
18. Briken V, Porcelli SA, Besra GS, Kremer L: Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 2004, 53:391-403.
19. Boehme C, Molokova E, Minja F, Geis S, Loscher T, Maboko L, Koulchin V, Hoelscher M: Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005, 99:893-900.
20. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker L-G, Wood R: Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009, 23:1875-1880.
21. Reither K, Saathoff E, Jung J, Minja LT, Kroidl I, Saad E, Huggett JF, Ntinginya EN, Maganga L, Maboko L, Hoelscher M: Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infect Dis 2009, 9:141.
22. Etard J-F, Ndiaye I, Thierry-Mieg M, Guèye NFN, Guèye PM, Lanièce I, Dieng AB, Diouf A, Laurent C, Mboup S, Sow PS, Delaporte E: Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 2006, 20:1181-1189.
23. Lawn SD, Badri M, Wood R: Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 2005, 19:2109-2116.
24. Wong EB, Omar T, Setlhako GJ, Osih R, Feldman C, Murdoch DM, Martinson NA, Bangsberg DR, Venter WDF: Causes of death on antiretroviral therapy: a post-mortem study from South Africa. PLoS One 2012, 7:e47542.
25. Cox JA, Lukande RL, Lucas S, Nelson AM, Van Marck E, Colebunders R: Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev 2010, 12(4):183-194.
26. Marras TK, Daley CL: Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002, 23:553-567.
27. Bonard D, Messou E, Seyler C, Vincent V, Gabillard D, Anglaret X: High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'Ivoire. AIDS 2004, 18:1961-1964.
28. McCarthy KD, Cain KP, Winthrop KL, Udomsantisuk N, Lan NTN, Sar B, Kimerling ME, Kanara N, Lynen L, Monkongdee P, Tasaneeyapan T, Varma JK: Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia. Am J Respir Crit Care Med 2012, 185:981-988.
29. Buijtels PCAM, van der Sande MAB, Parkinson S, Verbrugh HA, Petit PLC, van Soolingen D: Isolation of non-tuberculous mycobacteria at three rural settings in Zambia; a pilot study. Clin Microbiol Infect 2010, 16:1142-1148.
30. Crump JA, van Ingen J, Morrissey AB, Boeree MJ, Mavura DR, Swai B, Thielman NM, Bartlett JA, Grossman H, Maro VP, van Soolingen D: Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis 2009, 15:53-55.
31. Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, Hungerford L, Blattner W: Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria. PLoS One 2013, 8:e63170.
32. Kulich M, Rosenfeld M, Goss CH, Wilmott R: Improved survival among young patients with cystic fibrosis. J Pediatr 2003, 142:631-636.
33. Chalmers JD, Fleming GB, Hill AT, Kilpatrick DC: Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: a review and meta-analysis. Glycobiology 2011, 21(1460-2423 (Electronic)):271-282.
34. Olesen HV, Jensenius JC, Steffensen R, Thiel S, Schiøtz PO: The mannan-binding lectin pathway and lung disease in cystic fibrosis-disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clin Immunol 2006, 121:324-331.
35. Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Høiby N, Schwartz M, Koch C: Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999, 104:431-437.
36. Selvaraj P, Narayanan PR, Reetha AM: Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India. Tuber Lung Dis 1999, 79:221-227.
37. Søborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P: Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 2003, 188:777-782.
38. Garred P, Richter C, Andersen AB, Madsen HO, Mtoni I, Svejgaard A, Shao J: Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol 1997, 46:204-208.
39. Hoal-Van Helden EG, Epstein J, Victor TC, Hon D, Lewis LA, Beyers N, Zurakowski D, Ezekowitz AB, Van Helden PD: Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res 1999, 45(4 Pt 1):459-464.
40. Wood R, Racow K, Bekker L-G, Middelkoop K, Vogt M, Kreiswirth BN, Lawn SD: Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infect Dis 2012, 12:47.